Taraneh Ghaffari Farzi

Title: Innovations by Taraneh Ghaffari Farzi in Cardiac Monitoring

Introduction

Taraneh Ghaffari Farzi is an accomplished inventor based in San Jose, CA (US). She has made significant contributions to the field of cardiac monitoring through her innovative patent. Her work focuses on improving the methods for monitoring B-type natriuretic peptide (BNP) levels, which are crucial for assessing heart failure conditions.

Latest Patents

Taraneh holds a patent for "Implantable systems and methods for monitoring BNP levels, HF and MI." This patent describes methods for monitoring a patient's level of BNP and includes implantable cardiac systems capable of performing these methods. The system paces a ventricle for a specific duration to provoke a ventricular evoked response. A ventricular intracardiac electrogram (IEGM) is then obtained, which indicates the ventricular evoked response. Based on the IEGM, metrics such as peak-to-peak amplitude and maximum slope are determined to monitor the patient's BNP levels. This monitoring can help assess the patient's heart failure condition and predict risks of acute exacerbations or myocardial infarctions.

Career Highlights

Taraneh Ghaffari Farzi has established herself as a key figure in her field, working with Pacesetter, Inc. Her innovative approach to cardiac monitoring has the potential to significantly enhance patient care and outcomes.

Collaborations

She collaborates with notable colleagues, including Allen J Keel and Steve Koh, who contribute to her research and development efforts.

Conclusion

Taraneh Ghaffari Farzi's contributions to cardiac monitoring through her innovative patent demonstrate her commitment to advancing medical technology. Her work has the potential to improve the lives of patients suffering from heart conditions.